• English
  • Sign In
  • Contact Us
×
Catalog Products » Antibodies » Primary Antibodies » SARS-CoV-2 Spike S1 Antibody (HC2001), Human Chimeric

SARS-CoV-2 Spike S1 Antibody (HC2001), Human Chimeric

SARS-CoV-2 Spike S1 Antibody (HC2001), Human Chimeric

ELISA binding of SARS-CoV-2 Spike S1 Antibody (HC2001), Human Chimeric (GenScript, A02038) with recombinant SARS-CoV-2 Spike Protein S1 RBD(GenScript, Z03483) .
Coating antigen: recombinant SARS-CoV-2 Spike Protein S1 RBD, 0.5 µg/ml.
SARS-CoV-2 Spike S1 Antibody (HC2001), Human Chimeric (GenScript, A02038) dilution start from 25 µg/ml.
EC50= 0.088 µg/ml.

SARS-CoV-2 Spike S1 Antibody (HC2001), Human Chimeric

ELISA binding of SARS-CoV-2 Spike S1 Antibody (HC2001), Human Chimeric (GenScript, A02038) with recombinant SARS-CoV-2 NP&RBD(GenScript, Z03497).
Coating antigen: recombinant SARS-CoV-2 NP&RBD, 0.5 µg/ml.
SARS-CoV-2 Spike S1 Antibody (HC2001), Human Chimeric (GenScript, A02038) dilution start from 25 µg/ml.
EC50= 0.059 µg/ml.

Synonyms 2019-nCoV Spike S1 Antibody (HC2001), SARS-CoV-2 S1 RBD Antibody
Description SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2), also known as 2019-nCoV, is a positive-sense single-stranded RNA virus. It caused coronavirus disease 2019 (COVID-19). SARS-CoV-2 contains glycosylated spike (S) protein, which is composed of S1 subunit and S2 subunit. The S1 contains a receptor-binding domain (RBD) that can bind to ACE2 receptor on target cells.
SARS-CoV-2 Spike S1 Antibody (HC2001), Human Chimeric is produced from cell culture in vitro under conditions free from animal-derived components.
Conjugation Unconjugated
Purification Protein A
Clone HC2001 (monoclonal antibody)

Subclass Recombinant human IgG1
Concentration 1 mg/ml, supplied in PBS, pH 7.4, containing 0.02% sodium azide.
Specificity The product is specific for SARS-CoV-2 Spike Protein S1 subunit and its RBD domain.
Storage Store at -20°C. This product is stable for 1 year upon receipt, when handled and stored as instructed. Avoid repeated freezing and thawing cycles.
Note GenScript can customize this product per customer's request including product size, buffer components, etc.

Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product.
ELISA: 0.1-10 µg/ml
Other applications: user-optimized.

  • SARS-CoV-2 Spike S1 Antibody (HC2001), Human Chimeric
  • SARS-CoV-2 Spike S1 Antibody (HC2001), Human Chimeric

    ELISA binding of SARS-CoV-2 Spike S1 Antibody (HC2001), Human Chimeric (GenScript, A02038) with recombinant SARS-CoV-2 Spike Protein S1 RBD(GenScript, Z03483) .
    Coating antigen: recombinant SARS-CoV-2 Spike Protein S1 RBD, 0.5 µg/ml.
    SARS-CoV-2 Spike S1 Antibody (HC2001), Human Chimeric (GenScript, A02038) dilution start from 25 µg/ml.
    EC50= 0.088 µg/ml.

  • SARS-CoV-2 Spike S1 Antibody (HC2001), Human Chimeric
  • SARS-CoV-2 Spike S1 Antibody (HC2001), Human Chimeric

    ELISA binding of SARS-CoV-2 Spike S1 Antibody (HC2001), Human Chimeric (GenScript, A02038) with recombinant SARS-CoV-2 NP&RBD(GenScript, Z03497).
    Coating antigen: recombinant SARS-CoV-2 NP&RBD, 0.5 µg/ml.
    SARS-CoV-2 Spike S1 Antibody (HC2001), Human Chimeric (GenScript, A02038) dilution start from 25 µg/ml.
    EC50= 0.059 µg/ml.




Notice there is no results found, you can visit "Citations Database" for other results.







For more documents, please visit "Technical Support".

Cat. No. A02038
Size
Price
100 µg $375.00
1 mg Quote